心房颤动导管消融的适应症

O. S. Stychynskyi, P. O. Almiz
{"title":"心房颤动导管消融的适应症","authors":"O. S. Stychynskyi, P. O. Almiz","doi":"10.30702/ujcvs/22.30(04)/sa048-111114","DOIUrl":null,"url":null,"abstract":"Since the introduction of catheter ablation of atrial fibrillation (AF), it developed from a specialized experimental procedure into a common treatment option to prevent recurrent AF. In recent years substantial improvement has been made in the equipment and techniques used in catheter ablation of AF. The volume of procedures expanded year after year. Naturally, this has been reflected on indications for catheter ablation. \nThe aim. To study the changes in indications for catheter ablations of AF which has occurred during the last decade, according to European and American literature. \nMaterials and methods. We reviewed four documents related to the management of AF: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation ofatrial fibrillation; 2017 HRS/EHRA/ECAS/APHRS/SOLEACE expert consensus statement on catheter and surgical ablation of atrial fibrillation; 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS; 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). \nResults. During the analyzed period there have been a lot of changes inindications for catheter ablation of AF. Recent years guidelines pointed out that a decision on AF catheter ablation should be based on the patient’s preferences. It is recommended to take into consideration the procedural risks andmajor risk factors of arrhythmia recurrence. All this should be discussed with patient. Today antiarrhythmic drugs still remain a first-line rhythm control therapy. Catheter ablation is recommended after drug therapy failure in patients with all clinical forms of AF. In AF patients with heart failure, when tachycardia-induced cardiomyopathy is highly probable, catheter ablation is recommended as a first-line therapy. \nConclusion. Catheter ablation is effective in maintaining sinus rhythm in patients with paroxysmal and persistent AF. Its role as a method of rhythm control has increased during thelast decade.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Indications for Catheter Ablation of Atrial Fibrillation\",\"authors\":\"O. S. Stychynskyi, P. O. Almiz\",\"doi\":\"10.30702/ujcvs/22.30(04)/sa048-111114\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since the introduction of catheter ablation of atrial fibrillation (AF), it developed from a specialized experimental procedure into a common treatment option to prevent recurrent AF. In recent years substantial improvement has been made in the equipment and techniques used in catheter ablation of AF. The volume of procedures expanded year after year. Naturally, this has been reflected on indications for catheter ablation. \\nThe aim. To study the changes in indications for catheter ablations of AF which has occurred during the last decade, according to European and American literature. \\nMaterials and methods. We reviewed four documents related to the management of AF: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation ofatrial fibrillation; 2017 HRS/EHRA/ECAS/APHRS/SOLEACE expert consensus statement on catheter and surgical ablation of atrial fibrillation; 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS; 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). \\nResults. During the analyzed period there have been a lot of changes inindications for catheter ablation of AF. Recent years guidelines pointed out that a decision on AF catheter ablation should be based on the patient’s preferences. It is recommended to take into consideration the procedural risks andmajor risk factors of arrhythmia recurrence. All this should be discussed with patient. Today antiarrhythmic drugs still remain a first-line rhythm control therapy. Catheter ablation is recommended after drug therapy failure in patients with all clinical forms of AF. In AF patients with heart failure, when tachycardia-induced cardiomyopathy is highly probable, catheter ablation is recommended as a first-line therapy. \\nConclusion. Catheter ablation is effective in maintaining sinus rhythm in patients with paroxysmal and persistent AF. Its role as a method of rhythm control has increased during thelast decade.\",\"PeriodicalId\":33680,\"journal\":{\"name\":\"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30702/ujcvs/22.30(04)/sa048-111114\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30702/ujcvs/22.30(04)/sa048-111114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

自心房颤动(AF)的导管消融引入以来,它从一种专门的实验手术发展成为预防房颤复发的常用治疗选择。近年来,房颤导管消融的设备和技术有了实质性的改进,手术数量逐年增加。当然,这也反映在导管消融的适应症上。的目标。根据欧美文献,研究近十年来房颤导管消融适应症的变化。材料和方法。我们回顾了四份与房颤管理相关的文件:2012年HRS/EHRA/ECAS专家共识声明:房颤导管和手术消融;2017年HRS/EHRA/ECAS/APHRS/SOLEACE房颤导管和手术消融专家共识声明;与EACTS合作制定的2016 ESC房颤管理指南;2020年ESC房颤诊断和治疗指南与欧洲心胸外科协会(EACTS)合作制定。结果。在分析期间,房颤导管消融的适应症发生了很多变化。近年来的指南指出,房颤导管消融的决定应根据患者的喜好。建议考虑手术风险和心律失常复发的主要危险因素。所有这些都应该和病人讨论。今天,抗心律失常药物仍然是控制心律的一线疗法。对于所有临床形式的房颤患者,在药物治疗失败后,推荐导管消融。对于房颤合并心衰患者,当极有可能发生心动过速引起的心肌病时,推荐导管消融作为一线治疗。结论。导管消融在维持阵发性和持续性房颤患者的窦性心律方面是有效的。在过去十年中,它作为一种心律控制方法的作用越来越大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Indications for Catheter Ablation of Atrial Fibrillation
Since the introduction of catheter ablation of atrial fibrillation (AF), it developed from a specialized experimental procedure into a common treatment option to prevent recurrent AF. In recent years substantial improvement has been made in the equipment and techniques used in catheter ablation of AF. The volume of procedures expanded year after year. Naturally, this has been reflected on indications for catheter ablation. The aim. To study the changes in indications for catheter ablations of AF which has occurred during the last decade, according to European and American literature. Materials and methods. We reviewed four documents related to the management of AF: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation ofatrial fibrillation; 2017 HRS/EHRA/ECAS/APHRS/SOLEACE expert consensus statement on catheter and surgical ablation of atrial fibrillation; 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS; 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Results. During the analyzed period there have been a lot of changes inindications for catheter ablation of AF. Recent years guidelines pointed out that a decision on AF catheter ablation should be based on the patient’s preferences. It is recommended to take into consideration the procedural risks andmajor risk factors of arrhythmia recurrence. All this should be discussed with patient. Today antiarrhythmic drugs still remain a first-line rhythm control therapy. Catheter ablation is recommended after drug therapy failure in patients with all clinical forms of AF. In AF patients with heart failure, when tachycardia-induced cardiomyopathy is highly probable, catheter ablation is recommended as a first-line therapy. Conclusion. Catheter ablation is effective in maintaining sinus rhythm in patients with paroxysmal and persistent AF. Its role as a method of rhythm control has increased during thelast decade.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
42
审稿时长
6 weeks
期刊最新文献
Analysis of the Use of Non-Invasive Lung Ventilation Support in Newborns and Young Children after Cardiac Surgery Features of the Course of Atrial Fibrillation in Patients with the History of COVID-19: Impact on the Possibility and Tactics of Restoring Sinus Rhythm Features of Catheter Treatment of Non-Isthmus-Dependent Atrial Flutter Issues of Organization of the Cardiac Surgical Care in Ukraine under Martial Law Hemostasiological Aspects of PCI: Periprocedural Changes in the Activity of the Platelet Link of Hemocoagulation on the Background of Prior Double Antiplatelet Therapy in Patients with Chronic Coronary Syndrome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1